Baxter International Inc at Barclays Global Healthcare Conference Transcript
Good morning, everybody. Luke Sergott, I'm the life science tools and diagnostics analyst at Barclays. Kind of pitching over here into the med device side and talking to Jay Saccaro and Clare Trachtman of Baxter. We're going to dig in here. But just to kick it off, if you guys want to do -- open up with a few things to say and then we can dig into questions.
Sure, Luke. Thanks for the invitation to the conference. Thanks for pitching in here, pinch-hitting. We appreciate you doing that. And it's nice to see everybody in person. It's hard to believe that we haven't been at this conference for several years. And -- but it is great to be back in person, with seeing a lot of folks that we haven't seen in so many years in person. So that's great.
And I think that for me, as I reflect back on the last couple of years, really pleased with the progress of our company. I mean, I think even more than that, the
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |